E89R
TEAS SECTION 8 & 9 RECEIVED
08/06/2026
Back to search
Official data from USPTO
NAGLAZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/06/2026
Trademark type
Word
Nice classes
5
Filing date
05/13/2005
Registration date
08/22/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/28/2015
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/08/2005
First use in commerce
06/08/2005
Drawing code
4
Owner type
03
Owner location
Novato, CA, US
Examiner
PHAM, LANA H
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
BioMarin Pharmaceutical Inc.
Representatives
Gregory J. Chinlund Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparationsnamely pharmaceuticals for use in treatment of lysosomal storage disorders
Publications
History of USPTO decisions and trademark events.
30 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/22/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/28/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/28/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/28/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
08/28/2015
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/22/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/05/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/05/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/04/2012
E815
TEAS SECTION 8 & 15 RECEIVED
03/06/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2006
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/07/2006
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/17/2006
PUBO
PUBLISHED FOR OPPOSITION
02/21/2006
NPUB
NOTICE OF PUBLICATION
02/01/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/09/2006
ALIE
ASSIGNED TO LIE
12/16/2005
CRML
CORRESPONDENCE MAILED
12/15/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2005
IUAA
USE AMENDMENT ACCEPTED
12/14/2005
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/14/2005
IUAF
USE AMENDMENT FILED
12/14/2005
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/14/2005
XAEC
EXAMINER'S AMENDMENT ENTERED
12/14/2005
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/14/2005
DOCK
ASSIGNED TO EXAMINER
12/10/2005
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/02/2005
NWAP
NEW APPLICATION ENTERED
05/20/2005
Continuous trademark protection
Get notified about every new filing that threatens NAGLAZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.